Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FFBAV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $476,939
Award facts
- Contract value 100% obligated
- $476,938.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $476,938.83 to AmerisourceBergen Drug Corp for the supply of Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price contract was competitively awarded with no set-aside designation and is scheduled for completion by September 24, 2025. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order represents a child contract under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products, including brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The DLA Troop Support Medical contract vehicle enables AmerisourceBergen to deliver pharmaceutical commodities to customers including the Defense Health Agency and U.S. Coast Guard, supporting military healthcare programs worldwide. This award reflects the company's competitive standing in federal pharmaceutical procurement and its role in ensuring pharmaceutical supply chain continuity for Department of Defense medical requirements.
Quick answers
Who was awarded contract SPE2DB25FFBAV?
SPE2DB25FFBAV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FFBAV worth?
The government has obligated $476,939 on SPE2DB25FFBAV.
Is contract SPE2DB25FFBAV an order under another contract?
Yes. SPE2DB25FFBAV is a delivery order under SPE2DB24D1021, an indefinite delivery contract.
Was contract SPE2DB25FFBAV competed?
The extent of competition for SPE2DB25FFBAV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award